Comfort Care a.s.
- Address
- Revolucni 765/19, Stare Mesto, 110 00 Prague, Czechia
Comfort Care a.s. - Diabetes Research Center
Comfort Care a.s. is a specialized clinical research facility dedicated to advancing treatment options for patients with metabolic disorders. The center focuses on innovative therapeutic approaches for diabetes management, with particular expertise in evaluating novel insulin formulations and combination therapies that improve patient outcomes and quality of life.
- Type 2 diabetes treatment optimization and glycemic control
- Novel insulin delivery systems and weekly insulin therapy
- Combination therapy approaches with GLP-1 receptor agonists
The research team at Comfort Care a.s. specializes in investigating advanced insulin intensification strategies, including the evaluation of insulin icodec combined with semaglutide for enhanced blood sugar management. Their work contributes to developing more convenient and effective treatment regimens that reduce the burden of daily diabetes management while achieving optimal glycemic targets for patients with type 2 diabetes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Comfort Care a.s.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for treatment intensification. | Novo Nordisk A/S | Phase III | Not Recruiting | Jan 2024 | May 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Insulin Icodec | 1 | Unknown | 2024-01-09 | 2024-01-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.